In contemporary business environments, business leaders need to make fast, responsive, timely, and quality decisions; it is through decisions made that competitiveness is attained in an organization.
To make effective decisions, there is need to have quality information about a situation to be able to formulate alternatives. With advancement in computer technology, scientists are developing better ways of researching and providing biology and medicine solutions; one current technology that has been adopted is bioinformatics.
Bioinformatics is advantageous to business leaders and managers as they offer recent reports on studies of a particular area to facilitate them manage their organizations effectively.
With the use of current technology, scientists are able to analyze the prevailing business environment and offer quality recommendations on the right products and services that the current generation requires. It is through the well research analysis and research that innovations and inventions have been adopted (Barnes & Gray, 2003).
The danger of using bioinformatics is the development of dependency syndrome, when using the method to advance in business or make business decisions, managers in an organization are only fed with fully baked information on what they ought to do; this deny them the chance to be creating and innovative.
Although bioinformatics aim at improving human live-hood, when reflecting from a business perspective, they level the playing ground of different companies in the field of biology and medicine, this deny individual company the competitiveness it might get from individual efforts.
To have bioinformatics structures in an organization is costly; this means that business leaders and managers have to part with a huge amount of capital to enact the structures.
The cost might not be proportionate to the gains from the process making the company suffer. The structure of bioinformatics only focuses on which new products and services need to be made but never gives recommendations on how to improve the production process (Ouellette, 2005).
One international company that uses bioinformatics is Glaxo Smith Kline (GSK), the company engages in the business of researching and making human medicine. when coming up with new products as well as when improving the available ones, the company ensures it has wide quality information that can assist it develop quality products than those made by its competitors.
Other than as a competing strategy, the management appreciates that its works affects peoples life thus they need to continually improve their products for the benefit of the society.
GMK’s research and development department is mandated with the role of establishing the right bioinformatics technology to use; they have subscribed to different companies and journals offering insights on the topic to ensure they understand what is happening on the ground.
Some of products that have been improved using bioinformatics at GMK include Beconase Allergy and Hayfever, Committed Quitters, and Astringosol (Baldi & Brunak, 2001).
Other than in human medicine, bioinformatics is used in other biology and medicine fields like plant fungi and bacteria prevention measures and in animal medication. Researchers in bioinformatics field focus on a certain area of interest research it comprehensively and write quality research journals to assist managers when making business decisions.
Bioinformatics offer managers in biology and medicine field the chance to use computer science and information technology application to innovate, invent, and develop their products. The main goal of bioinformatics is to offer quality and reliable information to improve biology and medicine fields.
References
Baldi, P. & Brunak, S. (2001). Bioinformatics: The Machine Learning Approach. New York: MIT Press, 2001.
Barnes, M.R. & Gray, I.C. (2003). Bioinformatics for Geneticists. New Jersey: Wiley.
Ouellette, B. (2005). Bioinformatics: A Practical Guide to the Analysis of Genes and Proteins. New Jersey: Wiley